SUMMARY
implantation of an autonomic defibrillator has disadvantages.7-11) Inoue et al1 reported the usefulness of ethyl alcohol or phenol directly injected into coronary artery in ablating VT. Although several investigators13,14) modifying their method using ethyl alcohol reported that it terminates VT, clinical application of this procedure is difficult because the technique of infusing ethanol into a coronary artery can lead to necrosis in normal and unrelated regions of the endocardium.15) Direct subendocardial injection of ethyl alcohol via a catheter was first reported by Weismulller et al, 16 ) who found that their procedure led to a controlled local lesion. However, they did not examine the procedure with respect to its possible usefulness in controlling VT. Therefore, the present study was designed to determine whether or not the direct injection of ethyl alcohol into the myocardium, wherein a lesion controlled for location and size would be inflicted, could be used to terminate VT without causing unnecessary damage in other areas of the myocardium. To accomplish this purpose, we used an endoscopic needle catheter to inject ethanol into the myocardium of a VT model following a technique that is used successfully in sclerotherapy for esophageal varices.17,1
MATERIALS AND METHOD
Epicardial experiment: Seventeen mongrel adult dogs of either sex, weighing 13-28kg, were anesthetized with ketamine hydrochloride, 2mg/kg IM followed by pentobarbital (30mg/kg, IV); additional doses were administered as needed to maintain deep anesthesia. The dogs were intubated with a cuffed endotracheal tube and ventilated with room air using a Harvard respirator. Under positive pressure ventilation, the chest was opened through a left thoracotomy at the fourth or fifth intercostal space and the heart was suspended in a pericardial cradle. A fluid-filled cannula was inserted into the left cervical artery and connected to a transducer (Statham p-23 dB) to monitor arterial pressure, and a left-cervical venous cannula was used to infuse normal saline at 30ml/h to replace spontaneous fluid loss. A 1ml syringe with a 26-gauge needle was carefully placed in the epicardium of the area between the first and second diagonal branch of the left anterior descending (LAD) coronary artery ( Figure 1 ) in preparation for aconitine administration. Surface electrocardiographic (ECG) lead II and arterial pressure were recorded throughout the experiment. A left ventricular electrogram (LVE) was also recorded using a bipolar electrogram catheter inserted from the right femoral artery. Recordings were made on a Nihonkoden recorder (RMC 1100) at paper speeds of 5, 10, 25, 50 and 100mm/sec, as needed. Recordings from Marquette Holter ambulatory monitoring leads, aVf and CM5, were maintained throughout the experiment. Once the animals had Figure 1 . Site of aconitine administration used to induce VT during open heart surgery in the dog, and of ethanol administration using direct injection into the epicardium to suppress the induced VT. Figure  4 ) . The Jpn Heart J September 1996 first three lines show the normal heart rate of the dog at the outset of the procedure, starting at 15:35. VT was induced shortly thereafter 15:38 (arrow) and was fully apparent and steady by 15:40. The administration of ethanol at 15:46 (point 1) was followed by an immediate cessation of VT for the remainder of that minute. However, VT resumed during the next minute (15:47) and continued until a further dose of ethanol was administered at time 15:50 (point 2). VT reappeared shortly thereafter and ethanol was again administered at 15:56 (point 3). Following a brief respite, VT resumed and a fourth dose of ethanol was administered at 16:02 (point 4). Thereafter, VT gradually diminished and a regular sinus rhythm was established by 16:07; systemic hemodynamics were stable thereafter. In another animal (#8), the aconitine induced VT was converted into a regular sinus rhythm immediately after ethanol administration into the epicardium. At the same time, systolic blood pressure rose dramatically from 74 to 100mmHg ( Figure 5 ). Gross and histologic examinations revealed myocar- dial necrosis following the administration of ethanol in all dogs studied. The necrosis was observed in all animals, i.e., those that reverted to regular sinus rhythms (group A, n=15) and those that died of VF (group B, n=2) following the epicardial administration of ethanol. Histologic examination showed no transmural necrosis and no luminal fibrin or thromboses in either group. The volume of necrosis in the dogs that reverted to regular sinus rhythm appeared to be larger than in those that died of VF (Table II) . Further, neither the depth nor the maximum diameters of the regions were different in the two groups (Table  II) . A typical example of the macroscopic extent of the lesion is shown in Figure  6 , and a typical example of the microscopic examination by HE staining is shown in Figure 7 .
Jpn Heart J September 1996 Figure 5 . The record of a case (dog #4) wherein the induced VT was converted to a normal sinus rhythm immediately after an ethyl alcohol injection into the epicardium. Systolic blood pressure immediately increased from around 50mmHg to 100 mmHg. ECG=surface electrocardiography; HBE=His bundle EGG; LVECG=left ventricular ECG; LUMP=LV monophasic potential ECG; AP=aortic pressure. that recovered to normal sinus rhythm were compared to the ethanol doses of the dogs that died of VF; there was no significant difference between the groups (Table V) . Further, there was no significant relationship between the dose of ethanol and VT duration (Figure 8 ).
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DISCUSSI
In this study, 15 dogs recovered from aconitine-induced VT after ethanol was injected directly into the epicardium, while 2 others died of VF following aconitine administration. In addition, 7 of the 13 dogs recovered from aconitineinduced VT after ethanol was injected into the endocardium with the Variocath type-C needle catheter, while 6 others died of VF. Pathologic examination suggested that injection of 96% ethanol directly into the epi-and endocardium created a necrotic myocardial region that could terminate the aconitine-induced VT. By keeping the size of the lesion small, effective VT suppression could be accomplished without inducing severe hypotension. In the surviving dogs, the blood pressures in both epi-and endocardial experiments were significantly higher than those pressures recorded in dogs that died of VF during the experiment. Therefore, the VF that led to the deaths probably resulted from a secondary subendocardial ischemia caused by hypotension. This seems likely because the blood pressure in these dogs could not be maintained despite the infusion of methoxamine.
Recent basic and clinical studies indicate that lesions induced by intracoronary injection of 50-100% ethanol can terminate VT. Inoue et al12) first reported that intra-coronary injection of 25% phenol or 50-100% ethanol could suppress aconitine-induced VT in dogs. Gursoy et al20) described the clinical use of ethanol injections into coronary arteries in treating recurrent sustained VT, and reported that ethanol injected into a tachycardia-related artery successfully terminated VT. However, a transient elevation of creatine phosphokinase (CPK) and chest pains followed shortly thereafter. De Paola et al21) also reported on the Jpn Heart J September 1996 use of 96% ethanol to generate transcoronary chemical ablations to control VT in chronic Chagas myocarditis; they claimed to successfully induce an ablation in the tachycardia-related coronary artery without a consequent acute clinical or laboratory deterioration of left ventricular function. However, because the proximal coronary artery supplies a large area, its use for ethanol infusion risks damage to an excessive amount of myocardium. Instead, intracoronary infusion of ethyl alcohol should be used in only selected instances, such as those in which there is an anatomically well-defined area of arrhythmogenic VT and where the infused coronary artery supplies the peripheral artery. In such cases there would be no chance of massive myocardial necrosis that could elevate the ST segment or the CPK. Surgical interventions for the treatment of VT have involved cryoablation techniques and direct transmural ventriculostomy. Cryosurgery for ablation of sustained monomorphic VT due to coronary artery disease has proven to be a useful procedure. However, since the depth of a cryolesion depends upon the duration and degree of freezing, the procedure can increase the duration of an operation. In any event, the depth of the lesion is difficult to evaluate with current techniques.22) Direct transmural ventriculostomy is a useful procedure for recurrent VT, but it poses a higher mortality risk than does ICD implantation23) and it requires an open heart endocardial resection approach that involves peeling off a layer of endocardium and/or often the resection of the rim of an aneurysm. ICD devices are now markedly improved over what they were in the past. Kron et al24) and others8-11) reported that ICD can be used for treating VT, and a randomized study of the use of an ICD for controlling VT in patients 2-4 weeks after MI has shown its effectiveness.25) However, such equipment is in the trial stage, and it is still to be determined whether or not an ICD is better than antiarrhythmic agents.26) One disadvantage is that the generator must be changed every few years, depending on its frequency of usage. Furthermore, an ICD is costly and somewhat risky. Nunain et al27) reported that hardware-related complications and/or inappropriate shocks have occurred in patients after ICD devices were implanted. Therefore, patients implanted with ICD devices may be subjected to additional and unnecessary physical stress. Weismuller et al15) reported on the feasibility of chemical ablation by a subendocardial injection of ethanol via a catheter. They recognized the possibility of generating a local necrotic area of limited and controlled size after 25 days of initial chemical ablation, and they further suggested the possibility of chemical ablation by direct injection into the endocardium. They also reported that the necrotic region created by an ethanol injection into the endocardium does not impair left ventricular function after 3 weeks because the initial zone of necrosis is nearly completely subsumed by retracting connective tissue. The present data suggest that both direct epi-and endocardial injection of ethanol can terminate VT, possibly by inducing ablation in the VT related epi-and endocardial region. However the doses of ethanol in those cases where VT was replaced by regular sinus rhythms were not significantly greater than in those cases where dogs died of VF. Further, there was no significant relationship between the dose of ethanol and VT duration. Therefore, optimal ethanol doses could not be determined in this study. The technique of ethanol administration used in the present study may be a more suitable procedure than radiofrequency ablation for a VT that originates at a deep region of the endocardium, since radiofrequency ablation cannot reach intermediate or epicardial regions. The present method may be superior for use in polymorphic VT because the necrotic region is rather large, although after several weeks necrotic regions might be replaced by retracting connective tissue.
There are several limitations in the present study. First, aconitine-induced VT differs from VT observed in patients. Aconitine-induced VT is believed to stem from enhancement after depolarization due to cathodal currents or in response to low external Ca++ concentrations, which in turn cause altered Na+ and Ca++ exchange.28) Therefore, the model used in the present study does not necessarily apply to other cases of VT that stem from depolarization induced automatically in the Purkinje fibers or ventricular muscle. Further, studies of chronic infarction with inducible VT in an animal model are also required to demonstrate the applicability and effectiveness of transluminal chemical catheter ablation in this situation. This study was limited in scope to a model in which recovery from VT was not followed beyond several hours.
Second, the injection of ethanol directly into the ventricular epi-and endocardium does not always result in ethanol entering the myocardium exclusively; some of the fluid may leak into the surrounding areas. This is substantiated by our finding that the amounts of ethanol injected via the endocardial approach may have been slightly greater than the amounts injected via the epicardial approach. However, there were no serious hemodynamic effects. Nevertheless , this point should be examined in detail in subsequent studies. Third, the possibility of perforation should be considered. In the Weismuller et al15) study, perforation occurred twice but there were no further complications. We did not encounter any perforations in the present study, possibly because we employed a fine needle catheter that is used clinically in our hospital for the treatment of esophageal varix and gastric ulcer. Nevertheless, in a clinical setting, application of this technique in cases having a thin ventricle (e.g., dilated cardiomyopathy) should be avoided because of the increased risk of perforation; further adjustment to make an appropriately sized lesion might be difficult .
Despite these limitations, the present pilot study suggests that such a technique might be feasible in a clinical setting. This would be true if a catheter is specially designed so that the balloon in the catheter tip is kept in the same Jpn Heart J September 1996 position inside the ventricle to minimize leakage of ethanol. In addition, this technique could be useful if conventional methods, such as antiarrhythmic agents and/or radio-frequency techniques, are unsuccessful.
In summary, VT induced by direct myocardial injection of aconitine into anesthetized dogs can be converted to regular sinus rhythm by direct epicardial or endocardial injection of ethanol into the same myocardial region. These preliminary data suggest the utility of this chemical ablation technique for terminating VT.
